Methylsulfonylmethane (MSM) Supplements Market Report 2026

The methylsulfonylmethane (msm) supplements market size has grown strongly in recent years. It will grow from $1.34 billion in 2025 to $1.47 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing prevalence of joint-related conditions, growing fitness and active lifestyle participation, expansion of dietary supplement availability, rising use of natural anti-inflammatory compounds, broader acceptance of sulfur-based supplements.

The methylsulfonylmethane (msm) supplements market size is expected to see strong growth in the next few years. It will grow to $2.07 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to growing adoption of preventive joint care solutions, rising demand for vegan and non-gmo msm products, expansion of personalized supplement regimens, increasing focus on mobility and aging wellness, growth of online supplement retail channels. Major trends in the forecast period include growing demand for joint health supplements, rising adoption of msm in sports nutrition, expansion of combination formulations with vitamins and minerals, increased focus on clean-label and allergen-free products, higher consumer awareness of inflammation management.

The rising prevalence of joint disorders is expected to drive the growth of the methylsulfonylmethane (MSM) supplements market in the coming years. Joint disorders are conditions that affect or inflame the joints, causing discomfort and restricted movement, including osteoarthritis and rheumatoid arthritis. The occurrence of these conditions is increasing due to factors such as sedentary lifestyles and obesity. MSM supplements are commonly used as a complementary approach to support joint health by reducing inflammation, alleviating pain, and potentially aiding cartilage repair, although patient adoption varies. For example, in March 2025, the Health Equity Evidence Centre, a UK-based organization, reported that 17.1 million people in England were living with a musculoskeletal (MSK) condition, including arthritis or persistent back or joint issues. Consequently, the growing prevalence of joint disorders is fueling the expansion of the methylsulfonylmethane (MSM) supplements market.

The increase in the aging population is expected to drive the growth of the methylsulfonylmethane (MSM) supplements market in the coming years. An aging population refers to a rising share of older individuals within a society due to longer life expectancy and lower birth rates. This demographic change is fueled by improvements in healthcare that have extended lifespan. MSM supplements are commonly used by older adults to support joint health, reduce inflammation, and maintain mobility, although usage may vary among individuals. For example, in January 2024, the Population Reference Bureau, a U.S.-based non-profit organization, reported that the number of Americans aged 65 and older is expected to increase from 58 million in 2022 to 82 million by 2050, representing a 47% rise. Over the same period, the share of this age group in the total U.S. population is projected to grow from 17% to 23%. Consequently, the rise in the aging population is contributing to the growth of the methylsulfonylmethane (MSM) supplements market.

Major companies operating in the methylsulfonylmethane (MSM) supplements market are concentrating on developing clinically validated formulations that promote joint health, mobility, and overall wellness through safe and effective nutritional solutions. For example, in June 2025, Balchem Corporation, a US-based health products manufacturing company, received Food with Functional Claims (FFC) approval from Japan’s Consumer Affairs Agency for Balchem’s OptiMSM, making it the first methylsulfonylmethane (MSM) product to gain this recognition. Supported by a clinical study demonstrating that a 2,000 mg daily dose improved joint comfort and reduced knee pain, this approval confirms OptiMSM’s safety and efficacy. Already GRAS-certified in the U.S., OptiMSM is recognized for supporting joint and connective tissue health by supplying essential sulfur for cartilage. The FFC approval allows manufacturers to highlight joint health claims on packaging, strengthening OptiMSM’s position in the joint health and mobility segment of Japan’s expanding functional food market.

Major companies operating in the methylsulfonylmethane (msm) supplements market are The Nature’s Bounty Co., NOW Health Group Inc. (NOW Foods), Thorne HealthTech Inc., Jarrow Formulas Inc., Life Extension Foundation Buyers Club Inc., Swanson Health Products Inc., KAL Vitamins (a brand of Nutraceutical Corporation), Pure Encapsulations LLC, Solgar Inc., NutraScience Labs Inc., NutraBio Labs Inc., Bulksupplements.com LLC, Pure Organic Ingredients LLC, Puritan’s Pride Inc., PharmaFreak Holdings Inc., Vita-Flex Nutrition Inc., Source Naturals Inc., Kala Health Inc., Zenwise LLC (Zenwise Health), Bergstrom Nutrition Inc.

North America was the largest region in the methylsulfonylmethane (MSM) supplements market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the methylsulfonylmethane (msm) supplements market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the methylsulfonylmethane (msm) supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the methylsulfonylmethane supplements market by increasing costs of imported sulfur compounds, encapsulation materials, flavoring agents, and packaging components. North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressure on finished supplement exports. These tariffs are increasing production costs and affecting retail pricing. However, they are also encouraging domestic sourcing of MSM compounds, localized manufacturing, and innovation in cost-effective supplement formulations.

The methylsulfonylmethane (msm) supplements market research report is one of a series of new reports that provides methylsulfonylmethane (msm) supplements market statistics, including methylsulfonylmethane (msm) supplements industry global market size, regional shares, competitors with a methylsulfonylmethane (msm) supplements market share, detailed methylsulfonylmethane (msm) supplements market segments, market trends and opportunities, and any further data you may need to thrive in the methylsulfonylmethane (msm) supplements industry. This methylsulfonylmethane (msm) supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Methylsulfonylmethane (MSM) supplements are dietary products that contain a naturally occurring sulfur compound, which helps support joint health, reduce inflammation, and promote healthy skin, hair, and nails. They are commonly used to enhance mobility, alleviate pain, and maintain overall connective tissue health.

The main product forms of methylsulfonylmethane (MSM) supplements include powders, capsules, tablets, liquids, and softgels. Powders offer a flexible option that can be easily blended with water, juice, or other beverages. These supplements come in various formulations, such as organic MSM supplements, synthetic MSM supplements, non-GMO MSM supplements, vegan MSM supplements, and allergen-free MSM supplements. They are distributed through channels including online retailers, supermarkets or hypermarkets, health and wellness stores, pharmacies and drugstores, and direct sales. They are used for purposes such as supporting joint health, skin care, allergies and immune function, sports nutrition, and others, targeting users such as athletes and bodybuilders, health-conscious individuals, people with joint disorders, general fitness enthusiasts, and the aging population.

The methylsulfonylmethane (MSM) supplements market consists of sales of gummies, chewable supplements, effervescent granules, topical creams, gels, lotions, and functional beverages. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.